Quantitative analysis for GH Research PLC (GHRS) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (58.0) (grade B). Gem alpha score: 38.0. 29 signals analyzed (24 differentiated alt-data).
GHRS stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $20.14 | $18.89 | $19.16 |
| 2026-05-11 | $22.21 | $21.02 | $21.26 |
| 2026-05-21 | $22.60 | $21.64 | $21.77 |
| 2026-06-03 | $24.85 | $23.85 | $24.43 |
| 2026-06-15 | $21.58 | $20.12 | $20.37 |
| 2026-06-26 | $28.32 | $25.08 | $28.22 |
| 2026-07-09 | $27.46 | $26.50 | $27.20 |
| 2026-07-21 | $28.50 | $27.52 | $28.35 |
| 2026-07-31 | $28.85 | $27.86 | $28.07 |
| 2026-08-12 | $30.68 | $29.25 | $30.24 |
| 2026-08-24 | $28.60 | $27.24 | $28.10 |
| 2026-09-03 | $28.33 | $27.58 | $27.92 |
How GH Research PLC stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| QURE | uniQure N.V. | $1.5B | 38.0 |
| ATAI | Atai Beckley N.V | $1.5B | — |
| IMTX | Immatics N.V. | $1.5B | — |
| IMCR | Immunocore Holdings plc | $1.5B | — |
View all Health Care stocks by valuation and signals →
GH Research PLC (GHRS) scores Buy (58.0), and the composite conceals a 62-point disagreement between its dimensions. It is strongest on analyst consensus at 88 and ML forecast at 75, and weakest on AI Alpha (gem) at 26. A stock can carry analyst consensus that high while AI Alpha (gem) sits at 26; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 88 |
| ML forecast | 75 |
| valuation | 72 |
| technicals | 69 |
| AI Alpha (gem) | 26 |
StoQuant analyzes 29 signals (24 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on GH Research PLC (GHRS): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/GHRS"><img src="https://stoquant.com/badge/GHRS.svg" alt="GH Research PLC (GHRS) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.